• Return to Headlines

Karyopharm Thera Down 28.3% Since SmarTrend Downtrend Call (KPTI)

By James Quinn

SmarTrend identified a Downtrend for Karyopharm Thera (NASDAQ:KPTI) on September 27th, 2018 at $17.38. In approximately 2 weeks, Karyopharm Thera has returned 28.35% as of today's recent price of $12.45.

Over the past year, Karyopharm Thera has traded in a range of $6.27 to $21.50 and is now at $12.45, 99% above that low. Over the past week, the 200-day moving average (MA) has gone up 0.6% while the 50-day MA has declined 1.5%.

Karyopharm Therapeutics, Inc. provides biopharmaceutical products and services. The Company develops and discovers drugs for the treatment of cancer, inflammation, and diseases related to cell proliferation through activity modulation of critical pathways. Karyopham Therapeutics serves the healthcare industry throughout the United States and Germany.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Karyopharm Thera.

Log in and add Karyopharm Thera (KPTI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights karyopharm thera

Ticker(s): KPTI